| Ytd | -26.06% | |
| 1y | -10.90% |
| Open | 1.34 | Prev Close | 1.34 | Low | 1.30 | High | 1.41 | Mkt Cap | 178.28M |
| Vol | 91.75K | Avg Vol | 595.02K | EPS | -2.01 | P/E | N/A | Forward P/E | -39.70 |
| Beta | -0.53 | Short Ratio | 4.26 | Inst. Own | 26.20% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-01 | 50-d Avg | 1.56 | 200-d Avg | 1.60 | 1yr Est | 5.76 |
WALD News
LONDON, July 30, 2026 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or “the Compan
Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand b
LONDON, June 15, 2026 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Compan
Canaccord Genuity analyst Susan Anderson maintains Waldencast (NASDAQ:WALD) with a Buy and raises
Waldencast plc (NASDAQ:WALD) ("Waldencast" or "the Company") today announced that it
LONDON, June 01, 2026 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or “the Compan
Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part
Data from the ALOHA Program and NU-GEN™ Cellular Renewal Serum Showcase Results to Help Drive Practi
A multi-city pop-up introducing consumers to the future of skincare and longevity innovation A multi
Sun Shield™ Mineral UV Barrier Protect Broad Spectrum SPF 40 delivers advanced mineral protection wi
Seagate Technology Holdings (STX) shares rose 18% in pre-market trading after reporting strong Q3 re
LONDON, April 28, 2026 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Compa
Waldencast PLC (NASDAQ: WALD - Get Free Report) saw a significant increase in short interest during
The clinically proven formula pairs NAD+ with its precursors to replenish skin cells and address nin
Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part
ProMD's multi-location physician led network will participate in Obagi's ALOHA Program as part of a
Telsey Advisory Group analyst Dana Telsey maintains Waldencast (NASDAQ:WALD) with a Market Perfor
Canaccord Genuity analyst Susan Anderson maintains Waldencast (NASDAQ:WALD) with a Buy and lowers
Shares of Waldencast PLC (NASDAQ: WALD - Get Free Report) have received an average rating of "Modera
Waldencast (NASDAQ:WALD) reported quarterly losses of $(2.01) per share which missed the analyst con
FY 2025 net revenue of $272.1 million, flat to FY 2024, and Adjusted EBITDA of $16.1 million Q4 2025
LONDON, March 11, 2026 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global m
Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part
Schweiger selected as a leading dermatology platform partner due to its commitment to clinical excel
Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part
It's a Secret Med Spa selected as a premier luxury med spa partner due to its commitment to excellen
Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part
Aesthetic Record selected as a leading aesthetics EMR and practice management partner due to its com
Shares of Waldencast PLC (NASDAQ: WALD - Get Free Report) have received an average recommendation of
Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part
DermFx selected as a leading regional med spa partner due to its commitment to exceptional patient c
Moxie selected as a leading aesthetic practice software and support partner for its commitment to in
Obagi Medical ("Obagi"), a leader in advanced skincare innovation, the originator of medical
The dermatologist-tested duo pairs gentle chemical resurfacing with daily hydration and SPF protecti
Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part
Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part
Canaccord Genuity analyst Susan Anderson maintains Waldencast (NASDAQ:WALD) with a Buy and lowers
Telsey Advisory Group analyst Dana Telsey downgrades Waldencast (NASDAQ:WALD) from Outperform to
Waldencast (NASDAQ:WALD) reported quarterly losses of $(0.16) per share which missed the analyst con
Waldencast plc, (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand
Waldencast plc (NASDAQ:WALD), a global multi-brand beauty and wellness platform, today announced tha
Waldencast plc (NASDAQ:WALD), a global multi-brand beauty and wellness platform, today announced tha
Telsey Advisory Group analyst Dana Telsey maintains Waldencast (NASDAQ:WALD) with a Outperform an
